Literature DB >> 23430883

Altered carbon dioxide metabolism and creatine abnormalities in rett syndrome.

Nicky S J Halbach1, Eric E J Smeets, Jörgen Bierau, Irene M L W Keularts, Guy Plasqui, Peter O O Julu, Ingegerd Witt Engerström, Jaap A Bakker, Leopold M G Curfs.   

Abstract

Despite their good appetite, many females with Rett syndrome (RTT) meet the criteria for moderate to severe malnutrition. Although feeding difficulties may play a part in this, other constitutional factors such as altered metabolic processes are suspected. Irregular breathing is a common clinical feature, leading to chronic respiratory alkalosis or acidosis. We assumed that these changes in intracellular pH cause disturbances in the metabolic equilibrium, with important nutritional consequences. The study population consisted of a group of thirteen well-defined RTT girls with extended clinical, molecular and neurophysiological assessments. Despite normal levels of total dietary energy and protein intakes, malnutrition was confirmed based on significantly low fat-free mass index (FFMI) values. Biochemical screening of multiple metabolic pathways showed significantly elevated plasma creatine concentrations and increased urinary creatine/creatinine ratio in five RTT girls. Four girls, 10 years and older, were forceful breathers, one 13-year-old girl had an undetermined cardiorespiratory phenotype. An isolated increase of the urinary creatine/creatinine ratio was seen in two girls, a 9-year old forceful and a 4-year old feeble breather. Given that the young girls are feeble breathers and the older girls are forceful breathers, it is impossible to determine whether the elevated creatine concentrations are due to increasing age or cardiorespiratory phenotype. Furthermore, MeCP2 deficiency may cause epigenetic aberrations affecting the expression of the creatine-transporter gene, which is located at Xq28. Further studies are required to confirm these findings and to provide greater insight into the pathogenesis of the abnormal creatine metabolism in RTT.

Entities:  

Year:  2011        PMID: 23430883      PMCID: PMC3509869          DOI: 10.1007/8904_2011_76

Source DB:  PubMed          Journal:  JIMD Rep        ISSN: 2192-8304


  26 in total

1.  Guidelines for reporting clinical features in cases with MECP2 mutations.

Authors:  A M Kerr; Y Nomura; D Armstrong; M Anvret; P V Belichenko; S Budden; H Cass; J Christodoulou; A Clarke; C Ellaway; M d'Esposito; U Francke; M Hulten; P Julu; H Leonard; S Naidu; C Schanen; T Webb; I W Engerstrom; Y Yamashita; M Segawa
Journal:  Brain Dev       Date:  2001-07       Impact factor: 1.961

2.  An update on clinically applicable diagnostic criteria in Rett syndrome. Comments to Rett Syndrome Clinical Criteria Consensus Panel Satellite to European Paediatric Neurology Society Meeting, Baden Baden, Germany, 11 September 2001.

Authors:  Bengt Hagberg; Folker Hanefeld; Alan Percy; Ola Skjeldal
Journal:  Eur J Paediatr Neurol       Date:  2002       Impact factor: 3.140

3.  X-linked creatine-transporter gene (SLC6A8) defect: a new creatine-deficiency syndrome.

Authors:  G S Salomons; S J van Dooren; N M Verhoeven; K M Cecil; W S Ball; T J Degrauw; C Jakobs
Journal:  Am J Hum Genet       Date:  2001-04-20       Impact factor: 11.025

4.  Quantitative 1H MR spectroscopic imaging in early Rett syndrome.

Authors:  A Horská; S Naidu; E H Herskovits; P Y Wang; W E Kaufmann; P B Barker
Journal:  Neurology       Date:  2000-02-08       Impact factor: 9.910

5.  Characterisation of breathing and associated central autonomic dysfunction in the Rett disorder.

Authors:  P O Julu; A M Kerr; F Apartopoulos; S Al-Rawas; I W Engerström; L Engerström; G A Jamal; S Hansen
Journal:  Arch Dis Child       Date:  2001-07       Impact factor: 3.791

6.  Magnetic resonance spectroscopy and analysis of MECP2 in Rett syndrome.

Authors:  Pek Lan Khong; Ching Wan Lam; Clara G C Ooi; Chun Hung Ko; Virginia C N Wong
Journal:  Pediatr Neurol       Date:  2002-03       Impact factor: 3.372

Review 7.  Clinical characteristics and diagnostic clues in inborn errors of creatine metabolism.

Authors:  C Stromberger; O A Bodamer; S Stöckler-Ipsiroglu
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

Review 8.  Proton MR spectroscopy in Rett syndrome.

Authors:  A Gökcay; O Kitis; O Ekmekci; H Karasoy; R N Sener
Journal:  Comput Med Imaging Graph       Date:  2002 Jul-Aug       Impact factor: 4.790

9.  Fat-free mass index and fat mass index percentiles in Caucasians aged 18-98 y.

Authors:  Y Schutz; U U G Kyle; C Pichard
Journal:  Int J Obes Relat Metab Disord       Date:  2002-07

10.  Brain metabolism in Rett syndrome: age, clinical, and genotype correlations.

Authors:  Alena Horská; Luciano Farage; Genila Bibat; Lídia M Nagae; Walter E Kaufmann; Peter B Barker; SakkuBai Naidu
Journal:  Ann Neurol       Date:  2009-01       Impact factor: 10.422

View more
  3 in total

Review 1.  Rett syndrome - biological pathways leading from MECP2 to disorder phenotypes.

Authors:  Friederike Ehrhart; Susan L M Coort; Elisa Cirillo; Eric Smeets; Chris T Evelo; Leopold M G Curfs
Journal:  Orphanet J Rare Dis       Date:  2016-11-25       Impact factor: 4.123

2.  Neurophysiology versus clinical genetics in Rett syndrome: A multicenter study.

Authors:  Nicky Halbach; Eric E Smeets; Peter Julu; Ingegerd Witt-Engerström; Giorgio Pini; Stefania Bigoni; Stig Hansen; Flora Apartopoulos; Robert Delamont; Kees van Roozendaal; Maria F Scusa; Paolo Borelli; Math Candel; Leopold Curfs
Journal:  Am J Med Genet A       Date:  2016-06-29       Impact factor: 2.802

3.  Pinpointing brainstem mechanisms responsible for autonomic dysfunction in Rett syndrome: therapeutic perspectives for 5-HT1A agonists.

Authors:  Ana P Abdala; John M Bissonnette; Adrian Newman-Tancredi
Journal:  Front Physiol       Date:  2014-05-30       Impact factor: 4.566

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.